What Pseudoviruses Bring to the Study of SARS-CoV-2
Engineered viruses that don’t replicate provide a tractable model for scientists to safely study SARS-CoV-2, including research into vaccine efficacy and emerging variants.
What Pseudoviruses Bring to the Study of SARS-CoV-2
What Pseudoviruses Bring to the Study of SARS-CoV-2
Engineered viruses that don’t replicate provide a tractable model for scientists to safely study SARS-CoV-2, including research into vaccine efficacy and emerging variants.
Engineered viruses that don’t replicate provide a tractable model for scientists to safely study SARS-CoV-2, including research into vaccine efficacy and emerging variants.
A large-scale shortage of respirators and face shields threatens progress in some labs that are currently trying to ramp up their studies of SARS-CoV-2.
A series of articles published in open access journal mBio underscores the variety in opinion on whether a transmissible H5N1 strain should be studied.